| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Generate Biomedicines, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 42,230 | 26 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GENB | Generate Biomedicines, Inc. | 26 Feb 2026 | 1 | $0 | 4 | Chief Medical Officer | 02 Mar 2026, 17:58 |
| GENB | Generate Biomedicines, Inc. | 26 Feb 2026 | 0 | $0 | 3 | Chief Medical Officer | 26 Feb 2026, 20:46 |